Treatment of Overt Primary Hypothyroidism
Start levothyroxine (LT4) immediately for this patient with overt primary hypothyroidism (elevated TSH 9.60 and low free T4 0.82). This represents clear thyroid hormone deficiency requiring replacement therapy 1.
Initial Dosing Strategy
The starting dose depends critically on patient age and cardiac status:
For Patients Under 50-60 Years Without Coronary Disease
- Start with 50 µg daily or calculate full replacement dose at approximately 1.6 µg/kg body weight 1
- Most young, healthy patients can tolerate starting at the full calculated dose 2
For Patients Over 50-60 Years OR With Known Coronary Disease
- Start low at 12.5-25 µg daily if coronary heart disease is present 1
- Start at 50 µg daily if over 50-60 years but no cardiac disease 1
- Elderly patients require 20-25% less per kilogram than younger patients due to decreased lean body mass 1
- Monitor closely for anginal symptoms - this is essential and may limit achieving full euthyroidism 1
Critical Pitfall: Adrenal Insufficiency
Before starting LT4, rule out adrenal insufficiency in patients with central hypothyroidism or those at risk 1. Thyroid hormone replacement can precipitate adrenal crisis if hypocortisolism is present. Treat with appropriate hydrocortisone doses first if adrenal insufficiency exists 1.
Administration Instructions
Take LT4 with water 30-60 minutes before breakfast for optimal absorption 1. Key points:
- Approximately 70% of oral LT4 is absorbed 1
- Avoid taking with substances that interfere with absorption (see medication interactions below)
- Store at 20°C-25°C, protected from light and moisture 1
- Consistency in timing enhances compliance 1
Monitoring and Dose Adjustment
Check TSH 4-8 weeks after initiating therapy 1. The timeline matters:
- Higher doses (50-75 µg) may show TSH decline within a month
- Smaller doses may require 8 weeks or longer before TSH plateaus 1
Make incremental changes of 12.5-25 µg daily initially, with even smaller adjustments as you approach target 1.
Treatment Target
The therapeutic goal is TSH within the normal reference range (0.4-4.0 mIU/L), with many experts targeting 0.5-2.0 mIU/L 2, 3. The TSH is the most reliable therapeutic endpoint for primary hypothyroidism 1. When TSH normalizes, free T4 will also be in normal range 1.
Long-term Monitoring
Once stable on an adequate dose:
- Recheck TSH at 6 months, then annually 1
- Some clinical manifestations (like chronic skin changes) may take 3-6 months to resolve even after TSH normalizes 1
Common Causes of Persistently Elevated TSH
If TSH remains elevated despite doses >200 µg/day, consider 1:
Non-compliance (most common cause) 1
- Consider weekly dosing if daily compliance is problematic 1
Malabsorption issues 1
- Medications interfering with absorption
- Gastrointestinal disorders
Drug interactions - avoid concurrent administration with:
- Calcium supplements
- Iron supplements
- Proton pump inhibitors
- Bile acid sequestrants
- Soy products 1
Avoiding Overtreatment
Overtreatment occurs in 20% of patients and must be avoided 1. Consequences include:
- Cardiovascular complications (especially atrial fibrillation in elderly) 1
- Accelerated bone loss in postmenopausal women 1
- Possible affective disturbances 1
The elderly and postmenopausal women are particularly vulnerable to these adverse effects 1.
Special Considerations
Pregnancy: Requirements increase during pregnancy and revert to baseline postpartum - adjust doses accordingly 1
Medication changes: When drugs affecting absorption, binding, or metabolism are added/discontinued, recheck thyroid levels within 4-8 weeks and continue monitoring every 4-8 weeks until stable 1
Weight loss and aging: Both decrease LT4 requirements 1